Notice of CEO Change at Polaris Pharmaceuticals (KY)
Polaris Pharmaceuticals (KY) (6550) announced a change in its CEO effective May 25. Chairman Chen Hsien-Che will serve as interim CEO.
📋 Article Processing Timeline
- 📰 Published: May 26, 2026 at 06:31
- 🔍 Collected: May 26, 2026 at 06:31 (0 min after Published)
- 🤖 AI Analyzed: May 26, 2026 at 07:43 (1h 11m after Collected)
Date: May 26, 2026
Announcement Date: May 25, 2026
Ticker: 6550
Company Name: Polaris Pharmaceuticals (KY)
Subject: Announcement regarding change of CEO
Date of Occurrence: May 25, 2026
Explanation:
1. Position: CEO
2. Date of change: May 25, 2026
3. Predecessor: Chen Hsien-Che, Chairman
4. Successor: Chen Hsien-Che, Chairman
5. Reason for change: New appointment
6. Effective date: May 25, 2026
7. Remarks: Mr. Chen Hsien-Che will serve as the interim CEO.
Announcement Date: May 25, 2026
Ticker: 6550
Company Name: Polaris Pharmaceuticals (KY)
Subject: Announcement regarding change of CEO
Date of Occurrence: May 25, 2026
Explanation:
1. Position: CEO
2. Date of change: May 25, 2026
3. Predecessor: Chen Hsien-Che, Chairman
4. Successor: Chen Hsien-Che, Chairman
5. Reason for change: New appointment
6. Effective date: May 25, 2026
7. Remarks: Mr. Chen Hsien-Che will serve as the interim CEO.
FAQ
What does the management change at Polaris Pharmaceuticals mean?
The Chairman temporarily assuming the CEO role signifies a centralized leadership structure.
What is Chen Hsien-Che's role at Polaris Pharmaceuticals?
He is the Chairman and currently the interim CEO.
When did this change take effect?
It was announced and took effect on May 25, 2026.